Macroaxis considers XTL Biopharmaceutica to be unknown risk. XTL Biopharmaceuticals shows Sharpe Ratio of -0.0357 which attests that the company had -0.0357% of return per unit of standard deviation over the last 2 months. Macroaxis philosophy towards determining risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. XTL Biopharmaceuticals exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out XTL Biopharmaceuticals Downside Deviation of 4.99, Risk Adjusted Performance of 0.0402 and Mean Deviation of 3.53 to validate risk estimate we provide.
|Horizon||30 Days Login to change|
XTL Biopharmaceutica Market Sensitivity
|As returns on market increase, returns on owning XTL Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, XTL Biopharmaceutica is likely to outperform the market. 2 Months Beta |Analyze XTL Biopharmaceuticals Demand TrendCheck current 30 days XTL Biopharmaceutica correlation with market (DOW)|
β = -0.8069
XTL Biopharmaceutica Central Daily Price Deviation
XTL Biopharmaceuticals Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
XTL Biopharmaceutica Projected Return Density Against MarketAssuming 30 trading days horizon, XTL Biopharmaceuticals Ltd has beta of -0.8069 . This means as returns on benchmark increase, returns on holding XTL Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, however, XTL Biopharmaceuticals Ltd is likely to outperform the market. Moreover, The company has an alpha of 0.2846 implying that it can potentially generate 0.2846% excess return over DOW after adjusting for the inherited market risk (beta).
Predicted Return Density
Assuming 30 trading days horizon, the coefficient of variation of XTL Biopharmaceutica is -2801.14. The daily returns are destributed with a variance of 13.46 and standard deviation of 3.67. The mean deviation of XTL Biopharmaceuticals Ltd is currently at 2.72. For similar time horizon, the selected benchmark (DOW) has volatility of 0.71
|Alpha over DOW||=||0.28|
|Beta against DOW||=||0.81|
XTL Biopharmaceutica Return Volatilitythe company accepts 3.6689% volatility on return distribution over the 30 days horizon. the entity inherits 0.6883% risk (volatility on return distribution) over the 30 days horizon.
XTL Biopharmaceuticals Ltd has a volatility of 3.67 and is 5.32 times more volatile than DOW. 32% of all equities and portfolios are less risky than XTL Biopharmaceutica. Compared to the overall equity markets, volatility of historical daily returns of XTL Biopharmaceuticals Ltd is lower than 32 (%) of all global equities and portfolios over the last 30 days. Use XTL Biopharmaceuticals Ltd to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of XTL Biopharmaceutica to be traded at S10.01 in 30 days. . As returns on market increase, returns on owning XTL Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, XTL Biopharmaceutica is likely to outperform the market.
XTL Biopharmaceutica correlation with market